High Tower Advisors, LLC Immunity Bio, Inc. Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
A detailed history of High Tower Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 47,061 shares of IBRX stock, worth $100,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,061
Previous 33,774
39.34%
Holding current value
$100,239
Previous $89,000
29.21%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
282Shares Held
128MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA27.7MShares$58.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$24.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$18.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$16.5 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$16.4 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $853M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...